65 related articles for article (PubMed ID: 8245437)
1. Functional effects of CD30 on a large granular lymphoma cell line, YT. Inhibition of cytotoxicity, regulation of CD28 and IL-2R, and induction of homotypic aggregation.
Bowen MA; Olsen KJ; Cheng L; Avila D; Podack ER
J Immunol; 1993 Dec; 151(11):5896-906. PubMed ID: 8245437
[TBL] [Abstract][Full Text] [Related]
2. Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines.
Gilfillan MC; Noel PJ; Podack ER; Reiner SL; Thompson CB
J Immunol; 1998 Mar; 160(5):2180-7. PubMed ID: 9498756
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of KOLT-2 antigen (CD28) by interleukin 2; role of IL-2R (p70).
Shindo T; Sugie K; Nakamura K; Tagaya Y; Maeda M; Uchiyama T; Sagawa K; Yokoyama M; Wada H; Hitomi S
Immunology; 1990 Sep; 71(1):63-9. PubMed ID: 2170270
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
Makrigiannis AP; Hoskin DW
J Immunol; 1997 Nov; 159(10):4700-7. PubMed ID: 9366393
[TBL] [Abstract][Full Text] [Related]
5. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
[TBL] [Abstract][Full Text] [Related]
6. CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C.
Teng JM; Liu XR; Mills GB; Dupont B
J Immunol; 1996 May; 156(9):3222-32. PubMed ID: 8617944
[TBL] [Abstract][Full Text] [Related]
7. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
Galea-Lauri J; Darling D; Gan SU; Krivochtchapov L; Kuiper M; Gäken J; Souberbielle B; Farzaneh F
J Immunol; 1999 Jul; 163(1):62-70. PubMed ID: 10384100
[TBL] [Abstract][Full Text] [Related]
8. Costimulation of human CD28- T cells by 4-1BB ligand.
Bukczynski J; Wen T; Watts TH
Eur J Immunol; 2003 Feb; 33(2):446-54. PubMed ID: 12645943
[TBL] [Abstract][Full Text] [Related]
9. Structure and expression of murine CD30 and its role in cytokine production.
Bowen MA; Lee RK; Miragliotta G; Nam SY; Podack ER
J Immunol; 1996 Jan; 156(2):442-9. PubMed ID: 8543792
[TBL] [Abstract][Full Text] [Related]
10. 4-1BBL enhances anti-tumor responses in the presence or absence of CD28 but CD28 is required for protective immunity against parental tumors.
Guinn BA; Bertram EM; DeBenedette MA; Berinstein NL; Watts TH
Cell Immunol; 2001 May; 210(1):56-65. PubMed ID: 11485353
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a novel monoclonal antibody against human perforin using transfected cell lines.
Schlesinger BC; Cheng L
Immunology; 1994 Feb; 81(2):291-5. PubMed ID: 8157278
[TBL] [Abstract][Full Text] [Related]
12. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor.
Hyodo Y; Matsui K; Hayashi N; Tsutsui H; Kashiwamura S; Yamauchi H; Hiroishi K; Takeda K; Tagawa Y; Iwakura Y; Kayagaki N; Kurimoto M; Okamura H; Hada T; Yagita H; Akira S; Nakanishi K; Higashino K
J Immunol; 1999 Feb; 162(3):1662-8. PubMed ID: 9973427
[TBL] [Abstract][Full Text] [Related]
13. Requirements for CD28-dependent T cell-mediated cytotoxicity.
Azuma M; Cayabyab M; Phillips JH; Lanier LL
J Immunol; 1993 Mar; 150(6):2091-101. PubMed ID: 8383716
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD30 ligand (CD153) on murine activated T cells.
Shimozato O; Takeda K; Yagita H; Okumura K
Biochem Biophys Res Commun; 1999 Mar; 256(3):519-26. PubMed ID: 10080930
[TBL] [Abstract][Full Text] [Related]
15. CD28-mediated cytotoxicity of YT natural killer cells on B7-positive targets induces rapid necrotic death independent of granule exocytosis.
Roger R; Bréard J; Comisso M; Bohuon C; Pallardy M; Bertoglio J
Cell Immunol; 1996 Feb; 168(1):24-32. PubMed ID: 8599836
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells.
Oshimi Y; Oda S; Honda Y; Nagata S; Miyazaki S
J Immunol; 1996 Oct; 157(7):2909-15. PubMed ID: 8816396
[TBL] [Abstract][Full Text] [Related]
17. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
18. Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines.
Sun R; Li AL; Wei HM; Tian ZG
Cell Res; 2004 Feb; 14(1):67-73. PubMed ID: 15040892
[TBL] [Abstract][Full Text] [Related]
19. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
[TBL] [Abstract][Full Text] [Related]
20. Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells.
Azzoni L; Zatsepina O; Abebe B; Bennett IM; Kanakaraj P; Perussia B
J Immunol; 1998 Oct; 161(7):3493-500. PubMed ID: 9759869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
